Free Trial
NASDAQ:QTRX

Quanterix (QTRX) Stock Price, News & Analysis

Quanterix logo
$7.55 -0.03 (-0.40%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$7.55 0.00 (0.00%)
As of 02/21/2025 05:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Quanterix Stock (NASDAQ:QTRX)

Key Stats

Today's Range
$7.42
$7.72
50-Day Range
$7.55
$12.08
52-Week Range
$7.41
$29.70
Volume
527,646 shs
Average Volume
621,560 shs
Market Capitalization
$290.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.25
Consensus Rating
Moderate Buy

Company Overview

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Quanterix Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
42nd Percentile Overall Score

QTRX MarketRank™: 

Quanterix scored higher than 42% of companies evaluated by MarketBeat, and ranked 668th out of 954 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Quanterix has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Quanterix has received no research coverage in the past 90 days.

  • Read more about Quanterix's stock forecast and price target.
  • Earnings Growth

    Earnings for Quanterix are expected to decrease in the coming year, from ($0.98) to ($1.33) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Quanterix is -7.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Quanterix is -7.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Quanterix has a P/B Ratio of 0.82. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Quanterix's valuation and earnings.
  • Percentage of Shares Shorted

    6.93% of the float of Quanterix has been sold short.
  • Short Interest Ratio / Days to Cover

    Quanterix has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Quanterix has recently increased by 12.87%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Quanterix does not currently pay a dividend.

  • Dividend Growth

    Quanterix does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.93% of the float of Quanterix has been sold short.
  • Short Interest Ratio / Days to Cover

    Quanterix has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Quanterix has recently increased by 12.87%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Quanterix has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Quanterix this week, compared to 5 articles on an average week.
  • Search Interest

    2 people have searched for QTRX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Quanterix insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.90% of the stock of Quanterix is held by insiders.

  • Percentage Held by Institutions

    86.48% of the stock of Quanterix is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Quanterix's insider trading history.
Receive QTRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quanterix and its competitors with MarketBeat's FREE daily newsletter.

QTRX Stock News Headlines

$5,000 DOGE check?
Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers. The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail.
Bullish Quanterix Insiders Loaded Up On US$831.7k Of Stock
See More Headlines

QTRX Stock Analysis - Frequently Asked Questions

Quanterix's stock was trading at $10.63 at the beginning of 2025. Since then, QTRX shares have decreased by 29.0% and is now trading at $7.55.
View the best growth stocks for 2025 here
.

Quanterix Co. (NASDAQ:QTRX) posted its earnings results on Monday, December, 23rd. The company reported ($0.22) EPS for the quarter. Quanterix had a negative trailing twelve-month return on equity of 11.74% and a negative net margin of 30.12%.

Quanterix (QTRX) raised $50 million in an initial public offering on Thursday, December 7th 2017. The company issued 3,300,000 shares at $14.00-$16.00 per share. J.P. Morga and Leerink Partners served as the underwriters for the IPO and BTIG and Evercore ISI were co-managers.

Top institutional investors of Quanterix include Ameriprise Financial Inc. (8.32%), Portolan Capital Management LLC (6.72%), Alliancebernstein L.P. (6.33%) and Vanguard Group Inc. (5.76%). Insiders that own company stock include David R Walt, E Kevin Hrusovsky, Masoud Toloue, Michael A Doyle, John J Fry, Dawn Mattoon, William P Donnelly, Mark T Roskey and David C Duffy.
View institutional ownership trends
.

Shares of QTRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Quanterix investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

Last Earnings
12/23/2024
Today
2/22/2025
Next Earnings (Estimated)
5/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:QTRX
Fax
N/A
Employees
460
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.25
High Stock Price Target
$28.00
Low Stock Price Target
$16.00
Potential Upside/Downside
+207.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$-28,350,000.00
Pretax Margin
-26.26%

Debt

Sales & Book Value

Annual Sales
$122.37 million
Book Value
$9.25 per share

Miscellaneous

Free Float
35,866,000
Market Cap
$290.83 million
Optionable
Optionable
Beta
1.33
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:QTRX) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners